JPMORGAN CHASE & CO - USANA HEALTH SCIENCES INC ownership

USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 190 filers reported holding USANA HEALTH SCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of USANA HEALTH SCIENCES INC
ValueSharesWeighting
Q3 2023$7,260,080
-15.1%
123,871
-8.7%
0.00%0.0%
Q2 2023$8,550,620
+66.5%
135,638
+66.2%
0.00%0.0%
Q1 2023$5,135,000
+127287.7%
81,627
+7.7%
0.00%0.0%
Q4 2022$4,031
-99.9%
75,779
-11.9%
0.00%0.0%
Q3 2022$4,818,000
-20.7%
85,967
+2.4%
0.00%0.0%
Q2 2022$6,077,000
-15.5%
83,980
-7.2%
0.00%0.0%
Q1 2022$7,191,000
-22.1%
90,507
-0.8%
0.00%0.0%
Q4 2021$9,229,000
+16.3%
91,193
+6.0%
0.00%0.0%
Q3 2021$7,935,000
-12.9%
86,056
-3.3%
0.00%0.0%
Q2 2021$9,113,000
+100.7%
88,971
+91.3%
0.00%0.0%
Q1 2021$4,540,000
+6.4%
46,514
-15.9%
0.00%0.0%
Q4 2020$4,265,000
+14.8%
55,321
+7.8%
0.00%0.0%
Q3 2020$3,714,000
+11.4%
51,315
+13.1%
0.00%0.0%
Q2 2020$3,333,000
+25.1%
45,381
-1.6%
0.00%0.0%
Q1 2020$2,665,000
-64.9%
46,130
-52.3%
0.00%0.0%
Q4 2019$7,590,000
+76.1%
96,641
+53.4%
0.00%0.0%
Q3 2019$4,309,000
+61.6%
63,005
+81.1%
0.00%0.0%
Q2 2019$2,667,000
-71.6%
34,781
-68.9%
0.00%
-50.0%
Q1 2019$9,385,000
+48.2%
111,904
+108.1%
0.00%
+100.0%
Q4 2018$6,332,000
-0.5%
53,783
+1.8%
0.00%0.0%
Q3 2018$6,367,000
+26.2%
52,819
+20.7%
0.00%0.0%
Q2 2018$5,045,000
+38.9%
43,757
+3.5%
0.00%0.0%
Q1 2018$3,631,000
+145.8%
42,276
+112.0%
0.00%
Q4 2017$1,477,000
+47.0%
19,941
+14.3%
0.00%
Q3 2017$1,005,000
-4.3%
17,440
+6.4%
0.00%
Q2 2017$1,050,000
+13.6%
16,385
+2.1%
0.00%
Q1 2017$924,000
-4.7%
16,044
+1.2%
0.00%
Q4 2016$970,000
-7.4%
15,848
+109.2%
0.00%
Q3 2016$1,048,000
-59.5%
7,575
-67.4%
0.00%
-100.0%
Q2 2016$2,589,000
-44.1%
23,228
-39.1%
0.00%0.0%
Q1 2016$4,630,000
-71.2%
38,139
-69.7%
0.00%
-75.0%
Q4 2015$16,101,000
-5.1%
126,030
-0.4%
0.00%
-20.0%
Q3 2015$16,967,000
+42.4%
126,584
+45.2%
0.01%
+66.7%
Q2 2015$11,914,000
+18.9%
87,182
-3.3%
0.00%
+50.0%
Q1 2015$10,020,000
+1.6%
90,166
-6.2%
0.00%0.0%
Q4 2014$9,858,000
+62.7%
96,090
+16.8%
0.00%
+100.0%
Q3 2014$6,059,000
-6.4%
82,257
-0.7%
0.00%
-50.0%
Q2 2014$6,470,000
-35.4%
82,798
-37.7%
0.00%
-33.3%
Q1 2014$10,012,000
+9.4%
132,896
+9.8%
0.00%0.0%
Q4 2013$9,149,000
+25.2%
121,049
+43.7%
0.00%
+50.0%
Q3 2013$7,310,000
+8.2%
84,224
-9.7%
0.00%0.0%
Q2 2013$6,753,00093,2950.00%
Other shareholders
USANA HEALTH SCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
DENALI ADVISORS LLC 50,729$3,190,8541.33%
Cypress Capital, LLC 12,227$769,0780.25%
DGS Capital Management, LLC 6,835$429,9220.24%
PZENA INVESTMENT MANAGEMENT LLC 818,384$51,476,3540.22%
WINTON GROUP Ltd 26,950$1,695,1550.10%
Renaissance Technologies 1,211,797$76,2220.10%
Covestor Ltd 1,602$1010.09%
ACADIAN ASSET MANAGEMENT LLC 267,057$16,7780.07%
Ifrah Financial Services, Inc. 3,368$211,8470.07%
CAXTON ASSOCIATES LP 5,928$372,8710.06%
View complete list of USANA HEALTH SCIENCES INC shareholders